A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

NCT03127319 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: apatinib docetaxel zoledronic
DRUG: docetaxel zoledronic

Sponsor

Affiliated Hospital of Hebei University